Outcomes and prognostic factors after surgical resection of hypopharyngeal and cervical esophageal carcinomas
- PMID: 12144188
Outcomes and prognostic factors after surgical resection of hypopharyngeal and cervical esophageal carcinomas
Abstract
Carcinomas of the hypopharynx and the cervical esophagus carry poor prognosis regardless of any treatment modality. To improve long-term survival, prognostic factors for overall survival after surgical resection of these tumors were investigated. Clinical and pathological data from 52 patients undergoing surgical resection for hypopharyngeal (n = 20) and cervical esophageal (n = 32) cancers were reviewed to assess treatment outcomes and prognostic factors. The in-hospital mortality and morbidity rates were 13.5% and 50%, respectively. The 5-year survival rate of the 52 patients was 31.2%. The depth of tumor invasion, quality of tumor clearance, gender of the patients, postoperative complications, and intramural metastasis were revealed by the univariate analysis to be significant prognostic factors. The first four of these factors were specified by the multivariate analysis as independent prognostic factors for overall survival. Complete clearance of loco-regional disease and prevention of postoperative complications are of particular importance for the improvement of long-term survival in patients with these cancers.
Similar articles
-
Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.Hepatogastroenterology. 1994 Jun;41(3):278-82. Hepatogastroenterology. 1994. PMID: 7959554 Clinical Trial.
-
A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction.J Surg Oncol. 2006 May 1;93(6):468-76. doi: 10.1002/jso.20472. J Surg Oncol. 2006. PMID: 16615159
-
Paratracheal lymph node involvement in advanced cancer of the larynx, hypopharynx, and cervical esophagus.Laryngoscope. 2003 Sep;113(9):1595-9. doi: 10.1097/00005537-200309000-00035. Laryngoscope. 2003. PMID: 12972940
-
Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068. Ann Thorac Surg. 2004. PMID: 15464466 Review.
-
[Cancer of the hypopharynx and cervical esophagus. Role and limits of the surgical treatment].Chirurgie. 1990;116(4-5):351-7; discussion 357-8. Chirurgie. 1990. PMID: 2096033 Review. French.
Cited by
-
Should the Supraclavicular Lymph Nodes be Considered Regional Lymph Nodes in Cervical Esophageal Cancer?Ann Surg Oncol. 2022 Jan;29(1):616-626. doi: 10.1245/s10434-021-10664-0. Epub 2021 Sep 3. Ann Surg Oncol. 2022. PMID: 34480288
-
Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer.Esophagus. 2018 Oct;15(4):281-285. doi: 10.1007/s10388-018-0627-7. Epub 2018 Jun 15. Esophagus. 2018. PMID: 29948480
-
Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.J Gastrointest Oncol. 2014 Dec;5(6):401-7. doi: 10.3978/j.issn.2078-6891.2014.053. J Gastrointest Oncol. 2014. PMID: 25436117 Free PMC article.
-
Resection status and margin control in intraoperative frozen sectioning analysis of oral squamous cell carcinoma.Oral Maxillofac Surg. 2024 Sep;28(3):1209-1218. doi: 10.1007/s10006-024-01238-x. Epub 2024 Mar 27. Oral Maxillofac Surg. 2024. PMID: 38532169 Free PMC article.
-
Clinicopathological features and surgical treatment of cervical oesophageal cancer.Sci Rep. 2017 Jun 12;7(1):3272. doi: 10.1038/s41598-017-03593-0. Sci Rep. 2017. PMID: 28607370 Free PMC article.
MeSH terms
LinkOut - more resources
Medical